Under a memorandum of understanding, AACC will help NCI's Clinical Proteomics Technologies for Cancer program in its efforts to connect lab workers with biologists and clinicians to speed development, optimization, and standards for using proteomics to detect cancer-relevant proteins/peptides in clinical specimens, AACC said.

AACC said that the memorandum provides a framework for pursuing collaborations and educational events covering clinical proteomics research and the need for standards, best practices, community reagents, and data policies.